Home Stocks Contineum Therapeutics, Inc. Insider trades Contineum Therapeutics, Inc. · NASDAQ:CTNM
Contineum Therapeutics, Inc. insider trades Contineum Therapeutics, Inc.'s insiders made 0 buys and 14 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.
Insider trades Insider Trade Shares Price Value Date Stengone Carmine N. Director, Officer: CEO and President
Sale 2,500 USD 16.46 US$41,150 Sep 8, 2026 Stengone Carmine N. Director, Officer: CEO and President
Sale 2,500 USD 16.01 US$40,025 Aug 3, 2026 Lorrain Daniel S. Officer: Chief Scientific Officer
Sale 25 USD 16.00 US$400 Jul 9, 2026 Lorrain Daniel S. Officer: Chief Scientific Officer
Sale 1,015 USD 16.00 US$16,240 Jul 8, 2026 Stengone Carmine N. Director, Officer: CEO and President
Sale 2,500 USD 16.00 US$40,000 Jul 8, 2026 Lorrain Daniel S. Officer: Chief Scientific Officer
Sale 5,852 USD 15.67 US$91,701 Jul 1, 2026 Lorrain Daniel S. Officer: Chief Scientific Officer
Sale 2,501 USD 16.24 US$40,616 Jul 1, 2026 Lorrain Daniel S. Officer: Chief Scientific Officer
Sale 28,826 USD 16.04 US$462K Jun 30, 2026 Stengone Carmine N. Director, Officer: CEO and President
Sale 10,000 USD 16.01 US$160K Jun 30, 2026 Watkins Tim Officer: CMO & Head of Development
Sale 10,833 USD 16.02 US$174K Jun 30, 2026 Lorrain Daniel S. Officer: Chief Scientific Officer
Sale 4,170 USD 13.16 US$54,877 Jun 1, 2026 Lorrain Daniel S. Officer: Chief Scientific Officer
Sale 3,870 USD 13.06 US$50,542 May 1, 2026 Lorrain Daniel S. Officer: Chief Scientific Officer
Sale 300 USD 13.84 US$4,152 May 1, 2026 Lorrain Daniel S. Officer: Chief Scientific Officer
Sale 4,170 USD 13.43 US$56,003 Apr 6, 2026